Viral and host factors that contribute to pathogenicity of enterovirus 71

Future Microbiology

Volumn 7, Issue 4, 2012, Pages 467-479

  Huang, Hsing I ^a   Weng, Kuo Feng ^a   Shih, Shin Ru ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

apoptosis; EV71; immunity; ITAF; pathogenesis; tropism

Indexed keywords

CALRETICULIN; CASPASE 8; CHAPERONE; GAMMA INTERFERON; GLYCOPROTEIN IIIA; HOST FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS RECEPTOR;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOPHAGY; BRAIN CELL; CELL DEATH; COXSACKIE VIRUS A; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; DENDRITIC CELL; DISEASE SEVERITY; ENCEPHALITIS; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; GLIOBLASTOMA; HELA CELL; HOST CELL; HUMAN; INNATE IMMUNITY; INTERNAL RIBOSOME ENTRY SITE; LEUKEMIA CELL LINE; LUNG EDEMA; MESENTERY LYMPH NODE; MICROVASCULAR ENDOTHELIAL CELL; NEUROBLASTOMA CELL; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHABDOMYOSARCOMA; RNA VIRUS; VIRAL TROPISM; VIRUS CAPSID; VIRUS MYOCARDITIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; VIRAL TROPISM;

HUMAN ENTEROVIRUS 71; PICORNAVIRIDAE; RNA VIRUSES;

EID: 84858974593     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.22     Document Type: Review

References (127)

1. Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129(3), 304-309 (1974).
2. Chumakov M, Voroshilova M, Shindarov L et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 60(3-4), 329-340 (1979).
3. Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch. Dis. Child. 55(8), 583-588 (1980).
4. Chan LG, Parashar UD, Lye MS et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis. 31(3), 678-683 (2000).
5. Ho M, Chen ER, Hsu KH et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341(13), 929-935 (1999).
6. Mao LX, Wu B, Bao WX et al. Epidemiology of hand, foot, and mouth disease and genotype characterization of enterovirus 71 in Jiangsu, China. J. Clin. Virol. 49(2), 100-104 (2010).
7. Wu Y, Yeo A, Phoon MC et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int. J. Infect. Dis. 14(12), E1076-E1081 (2010).
8. De W, Changwen K, Wei L et al. A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009. Arch. Virol. 156(6), 945-953 (2011).
9. Lum LC, Wong KT, Lam SK et al. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133(6), 795-798 (1998).
10. McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26(1), 91-107 (2002).
11. Wang SM, Liu CC, Tseng HW et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29(1), 184-190 (1999).
12. Wang SM, Ho TS, Lin HC, Lei HY, Wang JR, Liu CC. Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity. Eur. J. Clin. Microbiol. Infect. Dis. doi:10.1007/s10096-011-1432-6 (2011) (Epub ahead of print).
13. Chang LY, Lin TY, Hsu KH et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354(9191), 1682-1686 (1999).
14. Chang LY, King CC, Hsu KH et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 109(6), E88 (2002).
15. Melnick JL. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev. Infect. Dis. 6(Suppl. 2), S387-S390 (1984).
16. Brown BA, Oberste MS, Alexander JP Jr, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73(12), 9969-9975 (1999).
17. Shindarov LM, Chumakov MP, Voroshilova MK et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 23(3), 284-295 (1979).
18. Koroleva GA, Gracheva LA, Voroshilova MK. [Isolation of type 71 enterovirus from patients with a poliomyelitis-like disease during an outbreak in Bulgaria]. Vopr. Virusol. (5), 611-618 (1978).
19. Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol. 71(3), 217-227 (1982).
20. Samuda GM, Chang WK, Yeung CY, Tang PS. Monoplegia caused by enterovirus 71: an outbreak in Hong Kong. Pediatr. Infect. Dis. J. 6(2), 206-208 (1987).
21. Shimizu H, Utama A, Yoshii K et al. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J. Infect. Dis. 52(1), 12-15 (1999).
22. Yang F, Ren L, Xiong Z et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 47(7), 2351-2352 (2009).
23. Chen CY, Chang YC, Huang CC, Lui CC, Lee KW, Huang SC. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am. J. Neuroradiol. 22(1), 200-205 (2001).
24. Gau SS, Chang LY, Huang LM, Fan TY, Wu YY, Lin TY. Attention-deficit/ hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics 122(2), E452-E458 (2008).
25. Chang LY, Huang LM, Gau SS et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356(12), 1226-1234 (2007).
26. Steil BP, Barton DJ. Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Res. 139(2), 240-252 (2009).
27. Shih S-R, Stollar V, Li M-L. Host factors in enterovirus 71 replication. J. Virol. 85(19), 9658-9666 (2011).
28. Huang S-W, Kiang D, Smith DJ, Wang J-R. Evolution of re-emergent virus and its impact on enterovirus 71 epidemics. Exp. Biol. Med. 236(8), 899-908 (2011).
29. Wu KX, Ng MML, Chu JJH. Developments towards antiviral therapies against enterovirus 71. Drug Discov. Today 15(23-24), 1041-1051 (2010).
30. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10(11), 778-790 (2010).
31. Zhang D, Lu J, Lu J. Enterovirus 71 vaccine: close but still far. Int. J. Infect. Dis. 14(9), E739-E743 (2010).
32. Kung CM, King CC, Lee CN, Huang LM, Lee PI, Kao CL. Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J. Med. Virol. 79(1), 60-68 (2007).
33. Whitton JL, Cornell CT, Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3(10), 765-776 (2005).
34. Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56(5), 855-865 (1989).
35. Yamayoshi S, Yamashita Y, Li J et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15(7), 798-801 (2009). Identification of SCARB2 as an enterovirus 71 (EV71) receptor.
36. Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell. Biol. 13(3), 137-145 (2003).
37. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15(7), 794-797 (2009). Identification of PSGL-1 as an EV71 receptor.
38. Mistry N, Inoue H, Jamshidi F, Storm RJ, Oberste MS, Arnberg N. Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells. J. Virol. 85(21), 11283-11290 (2011).
39. Lin YW, Wang SW, Tung YY, Chen SH. Enterovirus 71 infection of human dendritic cells. Exp. Biol. Med. 234(10), 1166-1173 (2009).
40. Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 6, 141 (2009).
41. Nilsson EC, Jamshidi F, Johansson SM, Oberste MS, Arnberg N. Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J. Virol. 82(6), 3061-3068 (2008).
42. Shiroki K, Ishii T, Aoki T et al. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J. Virol. 71(1), 1-8 (1997).
43. Thompson SR, Sarnow P. Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology 315(1), 259-266 (2003).
44. Li R, Zou Q, Chen L, Zhang H, Wang Y. Molecular analysis of virulent determinants of enterovirus 71. PLoS ONE 6(10), E26237 (2011).
45. Arita M, Ami Y, Wakita T, Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J. Virol. 82(4), 1787-1797 (2008).
46. Chua BH, Phuektes P, Sanders SA, Nicholls PK, McMinn PC. The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89(Pt 7), 1622-1632 (2008).
47. Huang SC, Chang CL, Wang PS, Tsai Y, Liu HS. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J. Med. Virol. 81(7), 1241-1252 (2009).
48. pro kills cells by apoptosis. Virology 266(2), 352-360 (2000).
49. Chau DH, Yuan J, Zhang H et al. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 12(3), 513-524 (2007).
50. Li ML, Hsu TA, Chen TC et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293(2), 386-395 (2002).
51. Chang SC, Lin JY, Lo LY, Li ML, Shih SR. Diverse apoptotic pathways in enterovirus 71-infected cells. J. Neurovirol. 10(6), 338-349 (2004).
52. Liang CC, Sun MJ, Lei HY et al. Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J. Med. Virol. 74(4), 597-603 (2004).
53. Chen LC, Shyu HW, Chen SH, Lei HY, Yu CK, Yeh TM. Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J. Med. Virol. 78(6), 780-786 (2006).
54. Shih SR, Weng KF, Stollar V, Li ML. Viral protein synthesis is required for enterovirus 71 to induce apoptosis in human glioblastoma cells. J. Neurovirol. 14(1), 53-61 (2008).
55. Kuo RL, Kung SH, Hsu YY, Liu WT. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J. Gen. Virol. 83(Pt 6), 1367-1376 (2002). Demonstrates that EV71 2A induces apoptosis.
56. Chen TC, Lai YK, Yu CK, Juang JL. Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell. Microbiol. 9(11), 2676-2688 (2007).
57. Chen SC, Chang LY, Wang YW et al. SUMOylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. J. Biol. Chem. 286(36), 31373-31384 (2011).
58. Wong WR, Chen YY, Yang SM, Chen YL, Horng JT. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 78(1), 82-90 (2005).
59. Saraste A, Arola A, Vuorinen T et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc. Pathol. 12(5), 255-262 (2003).
60. Wang YF, Chou CT, Lei HY et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78(15), 7916-7924 (2004).
61. Lu M, Meng G, He YX et al. [Pathology of enterovirus 71 infection: an autopsy study of 5 cases]. Zhonghua Bing Li Xue Za Zhi 38(2), 81-85 (2009).
62. Han J, Ma XJ, Wan JF et al. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with hand-foot-mouth disease after recovery. BMC Infect. Dis. 10, 178 (2010).
63. Colbere-Garapin F, Duncan G, Pavio N, Pelletier I, Petit I. An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin. Clin. Diagn. Virol. 9(2-3), 107-113 (1998).
64. Baj A, Maccari G, Toniolo A. Detection of persistent polioviruses in patients with the post-polio syndrome. In: Communicating Current Research and Educational Topics and Trends in Applied Microbiology. Mendez-Vilas A (Ed.). Formatex, Spain, 859-867 (2007).
65. Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5(6), 527-549 (2009).
66. Orvedahl A, Macpherson S, Sumpter R Jr, Talloczy Z, Zou Z, Levine B. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 7(2), 115-127 (2010).
67. Yorimitsu T, Nair U, Yang Z, Klionsky DJ. Endoplasmic reticulum stress triggers autophagy. J. Biol. Chem. 281(40), 30299-30304 (2006).
68. Jheng JR, Lau KS, Tang WF, Wu MS, Horng JT. Endoplasmic reticulum stress is induced and modulated by enterovirus 71. Cell. Microbiol. 12(6), 796-813 (2010).
69. Yang C, Deng C, Wan J, Zhu L, Leng Q. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virol. J. 8, 306 (2011).
70. Huang SW, Lee YP, Hung YT et al. Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice. Respir. Res. 12, 147 (2011).
71. Chang LY, Hsiung CA, Lu CY et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr. Res. 60(4), 466-471 (2006).
72. Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 91(6), 632-635 (2002).
73. Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 36(3), 269-274 (2003).
74. Brennan K, Bowie AG. Activation of host pattern recognition receptors by viruses. Curr. Opin. Microbiol. 13(4), 503-507 (2010).
75. Sasaki O, Karaki T, Imanishi J. Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice. J. Infect. Dis. 153(3), 498-502 (1986).
76. Liu ML, Lee YP, Wang YF et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86(Pt 12), 3263-3269 (2005).
77. Mukherjee A, Morosky SA, Delorme-Axford E et al. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7(3), E1001311 (2011).
78. Kuo K-K, Chang J-S, Wang K-C, Chiang L-C. Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line. Am. J. Chin. Med. 37(2), 383-394 (2009).
79. Lei X, Liu X, Ma Y et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84(16), 8051-8061 (2010).
80. Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85(17), 8811-8818 (2011).
81. Hsia SH, Wu CT, Chang JJ et al. Predictors of unfavorable outcomes in enterovirus 71-related cardiopulmonary failure in children. Pediatr. Infect. Dis. J. 24(4), 331-334 (2005).
82. Chang LY, Lee CY, Kao CL et al. Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981. J. Formos. Med. Assoc. 106(2), 173-176 (2007).
83. Wu T-C, Wang Y-F, Lee Y-P et al. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J. Virol. 81(19), 10310-10315 (2007).
84. Chung Y-C, Ho M-S, Wu J-C et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26(15), 1855-1862 (2008).
85. Chen H-L, Huang J-Y, Chu T-W et al. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 26(23), 2882-2889 (2008).
86. Chung C-Y, Chen C-Y, Lin S-Y et al. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. Vaccine 28(43), 6951-6957 (2010).
87. Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J. Virol. 84(1), 661-665 (2010).
88. Zhu Z, Zhu S, Guo X et al. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol. J. 7, 300 (2010).
89. Diedrich S, Weinbrecht A, Schreier E. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch. Virol. 154(7), 1139-1142 (2009).
90. Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of coxsackie A16 and enterovirus 71 in Germany. Med. Microbiol. Immunol. 199(1), 45-51 (2010).
91. Wang SM, Lei HY, Huang KJ et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188(4), 564-570 (2003).
92. Chang LY, Hsia SH, Wu CT et al. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr. Infect. Dis. J. 23(4), 327-332 (2004).
93. Wang JR, Tsai HP, Chen PF et al. An outbreak of enterovirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and genetic analysis. J. Clin. Virol. 17(2), 91-99 (2000).
94. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM. Hepatitis C virus induces Toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J. Virol. 80(2), 866-874 (2006).
95. Kopf M, Ramsay A, Brombacher F et al. Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann. NY Acad. Sci. 762, 308-318 (1995).
96. Wang SM, Lei HY, Su LY et al. Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. Clin. Microbiol. Infect. 13(7), 677-682 (2007).
97. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J. Exp. Med. 170(6), 1859-1867 (1989).
98. Frei K, Lins H, Schwerdel C, Fontana A. Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152(6), 2720-2728 (1994).
99. Lin YC, Juan HC, Cheng YC. Ozone exposure in the culture medium inhibits enterovirus 71 virus replication and modulates cytokine production in rhabdomyosarcoma cells. Antiviral Res. 76(3), 241-251 (2007).
100. Poffenberger MC, Straka N, El Warry N, Fang D, Shanina I, Horwitz MS. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis. PLoS ONE 4(7), E6207 (2009).
101. Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, Chen SH. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J. Virol. 83(13), 6477-6483 (2009).
102. Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J. Virol. 85(7), 3067-3076 (2011).
103. Vreugdenhil GR, Wijnands PG, Netea MG, Van Der Meer JW, Melchers WJ, Galama JM. Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes. Cytokine 12(12), 1793-1796 (2000).
104. Biondillo DE, Konicek SA, Iwamoto GK. Interferon-gamma regulation of interleukin 6 in monocytic cells. Am. J. Physiol. 267(5 Pt 1), L564-L568 (1994).
105. Zhang X-M, Zhao H-L, Wang J-J et al. [Evaluation of immune responses and related patho-inflammatory reactions of a candidate inactivated EV71 vaccine in neonatal monkeys]. Zhonghua Yi Xue Za Zhi 91(28), 1977-1981 (2011).
106. Olsson T, Kelic S, Edlund C et al. Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification. Eur. J. Immunol. 24(2), 308-314 (1994).
107. Martin S, Maruta K, Burkart V, Gillis S, Kolb H. IL-1 and IFN-gamma increase vascular permeability. Immunology 64(2), 301-305 (1988).
108. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol. Today 12(3), A49-A53 (1991).
109. Wynn TA. IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456 (2003).
110. Gu R, Shampang A, Reilly A, Fisher D, Glass W, Ramsingh AI. IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis. Virology 395(1), 77-86 (2009).
111. 2 in viral replication. Cell Signal. 22(2), 234-246 (2010).
112. Tung WH, Sun CC, Hsieh HL, Wang SW, Horng JT, Yang CM. EV71 induces VCAM-1 expression via PDGF receptor, PI3-K/Akt, p38 MAPK, JNK and NF-kappaB in vascular smooth muscle cells. Cell Signal. 19(10), 2127-2137 (2007).
113. Zheng Z, Li H, Zhang Z et al. Enterovirus 71 2C protein inhibits TNF-alpha-mediated activation of NF-kappaB by suppressing IkappaB kinase beta phosphorylation. J. Immunol. 187(5), 2202-2212 (2011).
114. Chen LC, Yeh TM. Enterovirus 71 infection of human immune cells induces the production of proinflammatory cytokines. J. Biomed. Lab. Sci. 21(3), 82-89 (2009).
115. + dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J. Virol. 82(16), 8149-8160 (2008).
116. Kramer M, Schulte BM, Toonen LW et al. Echovirus infection causes rapid loss-of-function and cell death in human dendritic cells. Cell. Microbiol. 9(6), 1507-1518 (2007).
117. Wahid R, Cannon MJ, Chow M. Dendritic cells and macrophages are productively infected by poliovirus. J. Virol. 79(1), 401-409 (2005).
118. Lee JJ, Seah JB, Chow VT, Poh CL, Tan EL. Comparative proteome analyses of host protein expression in response to enterovirus 71 and coxsackievirus A16 infections. J. Proteomics 74(10), 2018-2024 (2011).
119. Cui L, Guo X, Qi Y et al. Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J. Biomed. Biotechnol. 2010, 425939 (2010).
120. De Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J. Leukoc. Biol. 66(5), 740-746 (1999).
121. Laszik Z, Jansen PJ, Cummings RD, Tedder TF, Mcever RP, Moore KL. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 88(8), 3010-3021 (1996).
122. Brown JB, Cheresh P, Zhang Z, Ryu H, Managlia E, Barrett TA. P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis. Inflamm. Bowel. Dis. doi:10.1002/ibd.21779 (2011) (Epub ahead of print).
123. Dole VS, Bergmeier W, Patten IS, Hirahashi J, Mayadas TN, Wagner DD. PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb. Haemost. 98(4), 806-812 (2007).
124. Engering A, Geijtenbeek TB, Van Vliet SJ et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168(5), 2118-2126 (2002).
125. Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 5(9), E1000593 (2009).
126. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol. Cell Neurosci. 7(5), 354-370 (1996).
127. Ho BC, Yu SL, Chen JJ et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 9(1), 58-69 (2011).